Latest Regulatory Compliance News

Cleo Diagnostics has completed alpha testing of its ovarian cancer pre-surgical triage assay kits, confirming robust performance and differentiation between benign and malignant disease. The company now moves forward to assay optimisation and manufacturing scale-up, edging closer to FDA submission and commercial launch.

Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.

Euro Manganese has appointed Martina Blahova as its permanent CEO, cementing leadership continuity as the company advances its strategic Chvaletice Manganese Project in Europe.

European Lithium Ltd has released compelling assay results from historical deep diamond drilling at its Tanbreez Rare Earth Project in Greenland, confirming high-grade rare earth oxides and significant gallium concentrations that support potential resource expansion.

Equinox Resources has successfully completed the first tranche of its $3.5 million capital raise, issuing nearly 31 million shares at 9.5 cents each. The second tranche, involving additional shares and options, is pending shareholder approval.

Dropsuite Limited shareholders have decisively backed the proposed acquisition by NinjaOne Australia, with 99.95% voting in favor. The deal now awaits final court approval before completion and shareholder payouts.

Yowie Group has announced an all-scrip off-market takeover bid for Keybridge Capital, offering one Yowie share per Keybridge share. The bid is subject to key regulatory and shareholder approvals, setting the stage for a significant consolidation in the ASX-listed consumer goods and investment sectors.

The NSW Court of Appeal has dismissed an appeal challenging the replacement of Keybridge Capital's directors and confirmed the end of its external administration, marking a pivotal governance shift for the investment group.

Highfield Resources announces the immediate resignation of CEO Ignacio Salazar, who played a pivotal role in advancing the Muga project. The company maintains a trading halt as it prepares to disclose funding arrangements.

Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.

Macquarie Group Limited reported a 5% increase in net profit to A$3.715 billion for FY2025, driven by growth in asset management and banking segments alongside a robust capital and liquidity position.

Macquarie Group reported a 5% rise in full-year net profit to A$3.715 billion for FY25, driven by growth across its diversified businesses and a solid capital position. The group’s assets under management reached A$941 billion, supported by strong home loan and deposit growth.